Investments
6Portfolio Exits
3Funds
2About BAMS Angel Fund
BAMS Angels Fund is an early-stage investment fund organisation focused on investment rounds between EUR 1 and 4 million. BAMS Angels Fund I (BAF I) was created in 2005 by bringing together 30 individual œangel investors and selected institutional investors under the management of an experienced investment team. It invested in 9 early-stage projects in and around Belgium. In 2009, Michel Helbig de Balzac, Maurice Olivier and Bart Luyten launched BAMS Angels Fund II (BAF II) with the aim of scaling up and leveraging the positive experience of BAF I. The target size of BAMS Angels Fund II is upwards of EUR 20 million. BAMS Angels Fund aims to cover the equity gap faced by most promising start-up companies on their path towards profitable growth. The Fund has the resources, knowledge, experience and agility to respond to the financial and management needs of those companies, and to work side-by-side with them towards the achievement of successful exits.
Want to inform investors similar to BAMS Angel Fund about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
BAMS Angel Fund Investments
6 Investments
BAMS Angel Fund has made 6 investments. Their latest investment was in Bone Therapeutics as part of their Series D on January 1, 2013.
BAMS Angel Fund Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/28/2013 | Series D | Bone Therapeutics | $8.2M | Yes | 1 | |
12/15/2011 | Series A | |||||
12/31/2010 | Angel - II | |||||
10/15/2010 | Series B | |||||
12/31/2008 | Angel |
Date | 1/28/2013 | 12/15/2011 | 12/31/2010 | 10/15/2010 | 12/31/2008 |
|---|---|---|---|---|---|
Round | Series D | Series A | Angel - II | Series B | Angel |
Company | Bone Therapeutics | ||||
Amount | $8.2M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 1 |
BAMS Angel Fund Portfolio Exits
3 Portfolio Exits
BAMS Angel Fund has 3 portfolio exits. Their latest portfolio exit was Nomadesk on February 17, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/17/2017 | Acquired | 1 | |||
Date | 2/17/2017 | ||
|---|---|---|---|
Exit | Acquired | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 1 |
BAMS Angel Fund Fund History
2 Fund Histories
BAMS Angel Fund has 2 funds, including BAMS Angels Fund II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
BAMS Angels Fund II | Early-Stage Venture Capital | Withdrawn | 1 | ||
BAMS Angels Fund I |
Closing Date | ||
|---|---|---|
Fund | BAMS Angels Fund II | BAMS Angels Fund I |
Fund Type | Early-Stage Venture Capital | |
Status | Withdrawn | |
Amount | ||
Sources | 1 |
BAMS Angel Fund Team
2 Team Members
BAMS Angel Fund has 2 team members, including current Managing Partner, Michel Helbig de Balzac.
Name | Work History | Title | Status |
|---|---|---|---|
Michel Helbig de Balzac | Entrepreneur Invest | Managing Partner | Current |
Name | Michel Helbig de Balzac | |
|---|---|---|
Work History | Entrepreneur Invest | |
Title | Managing Partner | |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
